Orchard Therapeutics
ORTX
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)
Orchard Therapeutics (ORTX) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $0.12 B
According to Orchard Therapeutics 's latest financial reports the company's total liabilities are $0.12 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Orchard Therapeutics - Total liabilities on balance sheet (from 2017 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 7.28% |
| 2021-12-31 | $0.11 B | 9.71% |
| 2020-12-31 | $0.10 B | 2.41% |
| 2019-12-31 | $0.10 B | 82.96% |
| 2018-12-31 | $54.7 M | 402.38% |
| 2017-12-31 | $10.88 M | -47.67% |
| 2016-12-31 | $20.8 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.69 M | -97.79% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 0.00% | 🇬🇧 UK |
 Novavax NVAX | $2.51 B | 1,960.86% | 🇺🇸 USA |
 Novocure
NVCR | $0.78 B | 542.28% | Jersey |